Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

IRLAB Therapeutics

IRLAB Therapeutics

Read in Swedish

IRLAB to present the company at ProHearings on September 29, 2022

07:00 / 28 September 2022 IRLAB Therapeutics Press release

Gothenburg, Sweden, September 28, 2022 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease, today announced that Richard Godfrey, CEO of IRLAB, will present the company at ProHearings on Thursday, September 29, 2022, at 10:20 am CEST.

The presentation and moderated Q&A session is broadcasted live via www.prohearings.com, where registration for in-person attendance at the venue in central Stockholm also is available. A recording of the presentation will be made available on our company website, www.irlab.se, following the event.

Show as PDF

MFN

This information was distributed by MFN https://www.mfn.se/